ArticleThe American journal of case reports2017

Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report.

Curtis Lachowiez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.